Clinical trials: Acute ACE-induced Angioedema
Angioedema
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
The investigators will conduct a double-blind, randomized controlled trial comparing the safety and effectiveness of ecallantide to conventional therapy.
- Trial name
- ACE (NCT01036659)
- Testing
- ecallantide - Kallikrein inhibitor that blocks the production of bradykinin
- Where
- 3 sites in United States
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Bernstein, Jonathan A., M.D.